Skip to content

Insider · CIK 0001985154

Fred Grossman

officer

Files at COYA (Coya Therapeutics, Inc.). First filing Nov 12, 2024, latest Nov 12, 2024.

Fred Grossman files SEC Form 4 as officer at COYA (Coya Therapeutics, Inc.). Since Nov 12, 2024, Fred Grossman has reported 1 open-market buy worth $20k and 0 open-market sells worth $0, the latest filed on Nov 12, 2024.

A track record needs three past buys with six months of prices behind them; Fred Grossman has 0, so none is measured yet.

The newest scored trade: bought $20k of COYA on Nov 11, 2024, filed Nov 12, 2024, scored 38 (weak).

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$20k bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

COYA: Coya Therapeutics, Inc.

COYAOct 9, 2026 · close 4.95

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
38Weak
COYAbuy 3
Coya Therapeutics, Inc.
$20k
2,710 shares
--

Transactions

Every row this insider has filed, 3 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jan 22, 2026COYA
Coya Therapeutics, Inc.
AGrant or award
Stock Option (right to buy)derivative
+140,041$0.00$0140,041Jan 26, 2026
Jan 9, 2025COYA
Coya Therapeutics, Inc.
AGrant or award
Stock Option (right to buy)derivative
+140,562$0.00$0140,562Jan 13, 2025
Nov 11, 2024COYA
Coya Therapeutics, Inc.
POpen-market purchase
Common Stock, par value $0.0001 per share
+2,710$7.37$20k2,710Nov 12, 2024

Questions about Fred Grossman

Answered from the filings on this page, as of the latest one.

Is Fred Grossman buying or selling?

Not in the last 12 months. Fred Grossman's latest open-market trade on SEC Form 4 was bought $20k of COYA on Nov 11, 2024.

How did Fred Grossman's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Fred Grossman has 0.

Where does Fred Grossman file Form 4?

Fred Grossman has filed Form 4 at COYA (Coya Therapeutics, Inc.) as Chief Medical Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Fred Grossman: insider trades and track record | InsiderTell